Ultimé Premium NAD+ III Boost (Cancelled from the ARTG under paragraphs 30(1A)(a), 30(2)(aa), and 30(2)(e) of the Act)
Product name
Ultimé Premium NAD+ III Boost
ARTG details
393959
Date action takes effect
Compliance action
Complementary medicine cancellation
Type of action
Cancelled from the ARTG under paragraphs 30(1A)(a), 30(2)(aa), and 30(2)(e) of the Act
Grounds for regulatory action
The medicine is not eligible for listing (paragraph 30(1A)(a) of the Act).
It appears to the Secretary that the presentation of the goods is unacceptable (paragraph 30(2)(aa) of the Act).
The goods do not conform to a standard applicable to the goods (paragraph 30(2)(e) of the Act).